New combo therapy aims to stop liver cancer return in hepatitis b patients
NCT ID NCT07553767
First seen Apr 28, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This early-phase study looks at whether adding peginterferon alfa-2β to standard antiviral drugs can improve outcomes for people with hepatitis B-related liver cancer after their tumor is surgically removed. About 156 adults aged 18 to 65 will receive either the combination or antivirals alone. The goal is to see if the combination can clear the hepatitis B surface antigen, reduce cancer recurrence, and improve long-term survival over 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ningbo Medical Center Lihuili Hospital
Ningbo, Zhejiang, 315000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ningbo Mingzhou Hospital (Affiliated to Zhejiang University)
Ningbo, Zhejiang, 315000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ningbo No.2 Hospital
Ningbo, Zhejiang, 315000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shulan (Hangzhou) Hospital
Hangzhou, Zhejiang, 310022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.